Minerva Neurosciences (NERV) Operating Expenses (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Operating Expenses data on file, last reported at $16.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 327.16% year-over-year to $16.7 million; the trailing twelve-month figure through Mar 2026 stood at $27.9 million (up 46.16% YoY), and the FY2025 full-year result was $15.1 million, down 30.87% from the prior year.
• Operating Expenses for Q1 2026 stood at $16.7 million, up from $5.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.7 million in Q1 2026 and bottomed at $2.8 million in Q3 2025.
• The 5-year median for Operating Expenses is $5.2 million (2022), against an average of $6.0 million.
• The widest annual swing landed in 2022, when Operating Expenses tumbled 76.28%; it then surged 327.16% in 2026.
• A 5-year view of Operating Expenses shows it stood at $5.1 million in 2022, then surged by 41.47% to $7.2 million in 2023, then slumped by 36.95% to $4.5 million in 2024, then climbed by 10.16% to $5.0 million in 2025, then jumped by 234.66% to $16.7 million in 2026.
• The last three Operating Expenses figures came in at $16.7 million (Q1 2026), $5.0 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison